Self-sampling for Non-attenders to Cervical Cancer Screening

Recruiting now · Not applicable

Conditions studied: Cervical Cancer, Cervical Dysplasia, Human Papillomavirus Infection

In brief

The trial will evaluate whether self-sampling and human papillomavirus (HPV) testing may increase cervical cancer screening attendance among under-screened women in Czech Republic. Different ways of offering self-sampling device will be evaluated.

Key facts

Study ID

NCT04226313

Run by

The Institute of Molecular and Translational Medicine, Czech Republic

People needed

15000

Starts

2019-09-23

Expected to finish

2026-12-01

Last updated by the study team

2026-03-23

Who can join

Age: 30 and older, up to 65. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Women with age 30-65 years; for arm A women > 65 years are allowed
• Women live in the Czech Republic.
• Women who have not participate in cervical cancer screening program in the Czech Republic for at least 3 years (Arm B and C).
• Women with completed informed consent.
• Women capable of self-sampling of cervicovaginal swab.

You may not qualify if…

• Pregnant women.
• Women with no sexual intercourse experience.
• Women after hysterectomy including cervix.

Where it is running

• University Hospital Olomouc — Olomouc, Czechia (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.